IRIS
SCARLATA, GIUSEPPE GUIDO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 113
AS - Asia 89
NA - Nord America 76
AF - Africa 1
Totale 279
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 76
SG - Singapore 68
IT - Italia 59
RU - Federazione Russa 13
DE - Germania 12
NL - Olanda 10
CN - Cina 9
GB - Regno Unito 6
AT - Austria 5
IN - India 4
FI - Finlandia 3
HK - Hong Kong 3
BG - Bulgaria 2
FR - Francia 2
PH - Filippine 2
PK - Pakistan 2
EG - Egitto 1
RS - Serbia 1
TW - Taiwan 1
Totale 279
Salva come PNG Salva come JPEG
Città #
Singapore 42
Santa Clara 33
Milan 8
Kiel 6
London 6
San Nicola Manfredi 6
Ashburn 5
Hangzhou 5
Rome 5
St Louis 5
Assago 4
Chicago 4
Boardman 3
Catania 3
Elk Grove Village 3
Helsinki 3
Hong Kong 3
Palermo 3
Shanghai 3
St Petersburg 3
Taranto 3
Vienna 3
Bari 2
Chennai 2
Fermo 2
Gatchina 2
Honolulu 2
Moscow 2
Nuremberg 2
Padova 2
Potenza 2
Thiruvananthapuram 2
Yekaterinburg 2
Amsterdam 1
Aversa 1
Bilthoven 1
Bolzano 1
Boydton 1
Cairo 1
Cosenza 1
Fayetteville 1
Manila 1
Perm 1
Rostov-on-Don 1
Taipei 1
Totale 193
Salva come PNG Salva come JPEG
Nome #
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 34
Gastrointestinal symptoms, dietary regimen and anxiety levels during the COVID-19 pandemic among medical students: results from a web-based survey 25
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 24
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 19
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 18
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 15
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease 13
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 12
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 11
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 11
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 10
Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway? 10
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 9
Comment on Meneghini et al. The Impact of Nutritional Therapy in the Management of Overweight/Obese PCOS Patient Candidates for IVF. Nutrients 2023, 15, 4444 9
Is the Mediterranean diet a good preventive measure for NASH? 9
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 8
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition 8
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 8
Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma 7
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 7
The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review 7
Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection 7
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 7
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 6
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series 6
Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study 5
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance 5
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors 5
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 4
Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience 4
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease 3
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review 3
Totale 329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 8 0 0 1 0 2
2023/202476 12 3 7 7 3 5 6 10 5 0 4 14
2024/2025242 28 7 23 14 43 64 16 20 17 7 3 0
Totale 329